Appointment booking for Dr. Daniel Anderson, MD is currently not available.Dr. Daniel Anderson, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Daniel Anderson, MD is a Internist in Salem, IN with over 18 years of experience. What is your opinion of Dr. Daniel Anderson, MD? Rate this provider below so other people can make informed decision.
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Daniel Anderson, MD has received over $3,050 which includes payments from the following companies:
$550.33 from AstraZeneca Pharmaceuticals LP
$427.40 from Novo Nordisk Inc
$427.06 from Pfizer Inc.
$399.98 from Janssen Pharmaceuticals, Inc
$293.33 from sanofi-aventis U.S. LLC
$227.28 from Medtronic USA, Inc.
$186.94 from GlaxoSmithKline, LLC.
$142.37 from LILLY USA, LLC
$82.38 from Boehringer Ingelheim Pharmaceuticals, Inc.
$42.22 from Grifols USA, LLC
$31.15 from Teva Pharmaceuticals USA, Inc.
$27.21 from Amgen Inc.
$23.67 from FOREST PHARMACEUTICALS, INC.
$23.64 from Coloplast Corp
$18.12 from E.R. Squibb & Sons, L.L.C.
$17.38 from TEI Biosciences Inc
$16.51 from Purdue Pharma L.P.
$15.77 from Ethicon US, LLC
$13.55 from Novartis Pharmaceuticals Corporation
$13.11 from Takeda Pharmaceuticals America, Inc.
Payments received by Dr. Daniel Anderson, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!